Beyond luminal narrowing: recurrent calcific embolism from a vulnerable non-stenotic carotid plaque
Abstract
Case Presentation: A 72-year-old male with hypertension, diabetes, and dyslipidemia presented with a minor acute ischemic stroke (AIS) (Central facial palsy and dysarthria). After initial evaluation and neuroimaging, he was discharged conservatively with dual antiplatelet therapy (DAPT). Computed tomographic angiography (CTA) revealed an irregular calcified plaque at the left internal carotid artery (ICA) origin, with approximately 40% stenosis. Eleven days post-discharge, he developed a central retinal artery occlusion (CRAO). Despite an unremarkable transthoracic echocardiography and regular sinus rhythm on conventional electrocardiography (ECG), without the possibility of a 24h heart rhythm registry acquisition, and taking into consideration the new visual deficit as well as the embolic aspect of the first stroke, the medical therapy was switched to anticoagulation using heparin. A new stroke syndrome with aphasia and weakness of the right hand was detected during magnetic resonance imaging around 20 days after anticoagulation. Non-contrast brain CT confirmed multiple punctate calcifications within the left cerebral sulci and the M2 branch, identifying the small calcified carotid plaque as the embolic source. Mechanical thrombectomy was deferred due to the distal and calcific nature of the embolus. Given the recurrent events within the same vascular territory despite optimal medical therapy, the patient underwent left ICA angioplasty. Post-procedure, unfortunately, he experienced transient hemodynamic instability and neurological worsening, with the NIHSS increasing from 7 to 11 points. Following stabilization in the intensive care unit, the patient was discharged with residual aphasia and right-sided paresis, maintained on DAPT with neurovascular follow-up. Discussion: Calcific cerebral embolism (CCE) is a dramatically challenging and underrecognized clinical entity, representing approximately 1% to 3% of all ischemic strokes. Its clinical impact is disproportionately high due to the unique physical properties of the emboli. Unlike thromboembolism, CCE involves hydroxyapatite fragments that are inherently resistant to fibrinolysis and often too rigid for successful mechanical thrombectomy. The "salted" appearance on CT (punctate hyperdensities) serves as a pathognomonic marker. This case underscores plaque morphology—specifically irregularity and calcification—may be more predictive of embolic risk than the degree of luminal narrowing, as demonstrated by the failure of anticoagulation and DAPT to prevent recurrence. Final Comments: The rarity of CCE often leads to diagnostic delays. This report emphasizes that irregular calcified plaques, even with <50% of stenosis, should be flagged as high-risk "vulnerable" lesions. Early recognition of calcific embolic patterns on neuroimaging is crucial, as these lesions are refractory to standard medical therapy and may necessitate early endovascular or surgical intervention to prevent recurrent stroke.